Repertoire Immune Medicines is a clinical-stage biotechnology company dedicated to discovering and developing a new category of immune medicines for cancer, autoimmune disorders, and infectious diseases. Leveraging its proprietary DECODE™ platform, Repertoire aims to understand the intricate language of the immune synapse—the T cell receptor (TCR)-epitope interactions—to design therapies that can precisely target disease. The company focuses on creating medicines that can harness the power of the immune system with greater specificity and efficacy, with a pipeline addressing significant unmet medical needs.
The Cambridge headquarters serves as the company's primary center for research and development, corporate operations, clinical development, and strategic leadership.
Located within the dynamic Kendall Square ecosystem, the facility likely features state-of-the-art laboratories for immunology, molecular biology, and bioinformatics, alongside modern office spaces designed to foster collaboration.
The work culture at Repertoire is characterized by a strong emphasis on scientific rigor, innovation, and collaboration. Employees are driven by a shared mission to translate groundbreaking science into transformative therapies for patients.
Its Kendall Square location provides strategic advantages, including proximity to world-class academic institutions, a rich talent pool, potential collaborators, and key investors, all crucial for a pioneering biotech.
While primarily based in Cambridge, MA, Repertoire Immune Medicines's impact is global through its research collaborations, potential international clinical trial sites, and engagement with the worldwide scientific and medical communities. The company's therapeutic focus addresses diseases affecting patients globally.
One Kendall Square, Building 600, Suite 203
Cambridge
MA
USA
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Repertoire Immune Medicines' leadership includes:
Repertoire Immune Medicines has been backed by several prominent investors over the years, including:
Repertoire Immune Medicines strengthened its leadership team over the past 12 months with the strategic appointments of a new Chief Scientific Officer and a new General Counsel in September 2023, enhancing its scientific and legal capabilities.
Discover the tools Repertoire Immune Medicines uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Repertoire Immune Medicines likely utilizes standard corporate email formats. Common patterns include [first_initial][last]@[domain] or [first].[last]@[domain]. The domain is repertoire.com.
Likely formats include [first_initial][last]@repertoire.com or [first].[last]@repertoire.com
Format
jdoe@repertoire.com
Example
75%
Success rate
Repertoire Immune Medicines News • January 9, 2024
Repertoire announced a significant publication in Nature Biotechnology detailing its DECODE™ discovery platform. The paper showcases the platform's ability to identify T cell receptor-epitope interactions at scale, providing novel insights into immune system engagement and guiding the development of targeted therapies....more
Repertoire Immune Medicines Press Release • September 7, 2023
Repertoire Immune Medicines announced the appointment of Thomas M. J. Möller, Ph.D., as Chief Scientific Officer and Joanne L. Kedenburg, J.D., as General Counsel. These key hires are set to bolster the company's scientific strategy and legal operations as it advances its pipeline....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Repertoire Immune Medicines, are just a search away.